(EMAILWIRE.COM, June 12, 2018 )
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding. The usage of hemostats must be quick, localized, and carefully regulated. Although, the usage of hemostats is not required until and unless the bleeding is heavy or the patient is suffering from congenital diseases or trauma defects.

Browse 199 market data Tables and 90 Figures spread through 159 Pages and in-depth TOC on "Hemostats Market"

http://www.marketsandmarkets.com/Market-Reports/hemostats-market-9571619.html

Early buyers will receive 10% customization on this report.

Factors such as increasing surgical procedures and rising number of insurance providers are driving the Hemostats Market. According to Center for Disease Control and Prevention (CDC), 51.4 Million surgeries have taken place in the U.S. in 2014. The increase in number of surgeries accelerates the demand for hemostats and thereby is driving the growth of the market. However, the high cost of products hinders the growth of the global Hemostats Market.

Based on product type, the global Hemostats Market is segmented into thrombin-based, oxidized regenerated cellulose based hemostats, combination hemostats, gelatin based hemostats, and collagen based hemostats. The thrombin based hemostats segment dominates the Hemostats Market and is projected to grow at a significant pace during the forecast period, in terms of value.

Based on geography, the global hemostat market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Each region is further segmented into countries, covering around 50 countries, globally. The market in the Americas is one of the key geographical segments that generate major revenue in the global Hemostats Market. The growth in the Americas Hemostats Market is attributed to the increase in number of surgical procedures. However, the Hemostats Market in Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. Increasing healthcare infrastructure along with rise in number of surgeries are propelling the growth of this market.

Major companies operational in the Hemostats Market are Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.).

Inquiry before Buying @
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=9571619

The research study is aimed at identifying emerging trends and opportunities in the global Hemostats Market along with detailed classifications, in terms of revenue. It provides comprehensive competitive landscape and identifies the key players with respect to market size and market share. The research study also includes a detailed segmentation of the global Hemostats Market on the basis of product type and geography. Apart from the market segmentation, this report also provides an in-depth analysis of the market by providing a detailed process flow diagram and market dynamics, such as drivers, restraints, and opportunities in the global Hemostats Market.

Browse Related Reports:

Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019.

http://www.marketsandmarkets.com/Market-Reports/hemostasis-coagulation-analyzer-market-197226392.html

Biosurgery Market by Type (Surgical Sealants, Hemostatic Agents, Soft Tissue Attachments, Adhesion Barriers, Bone Graft Substitutes), Application (Neurological, Cardiovascular, General, Orthopedic, Reconstructive) - Global Forecast to 2020.

http://www.marketsandmarkets.com/Market-Reports/biosurgery-market-166922302.html

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com